TradeHighPartialAccelerating
7.5
Big Pharma pours billions into China biotech, deepening US tech rivalry
Valor Econômico·CN · US·about 19 hours ago
China's domestic investment indicators are weakening, adding pressure on policymakers to boost stimulus spending. The slowdown signals a potential growth miss, raising expectations for fiscal or monetary easing. Uncertainty remains over the scale and timing of any new measures.